Sio Capital Management’s Emergent Biosolutions EBS Stock Holding History

Sio Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50,000	Closed	-$4.65M	–	81
2021 Q1	$4.65M	Buy	+50,000	New	+$5.12M	0.94%	36
2019 Q3	–	Sell	-48,400	Closed	-$2.34M	–	69
2019 Q2	$2.34M	Sell	48,400 -131,756	-73%	-$6.31M	0.56%	48
2019 Q1	$9.1M	Buy	180,156 +106,363	+144%	+$6.27M	2.46%	13
2018 Q4	$4.37M	Buy	73,793 +31,994	+77%	+$2.06M	1.59%	26
2018 Q3	$2.75M	Buy	+41,799	New	+$2.44M	0.94%	39
2018 Q1	–	Sell	-91,533	Closed	-$4.25M	–	34
2017 Q4	$4.25M	Buy	91,533 +1,265	+1%	+$53.2K	2.4%	16
2017 Q3	$3.65M	Buy	+90,268	New	+$3.27M	1.89%	19

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sio Capital Management's EBS Position: Q2 2021 in Review

Sio Capital Management sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 50,000 shares — an estimated $4.65M sold.

Sio Capital Management first reported a position in EBS in Q3 2017 and held it in 7 quarters. The position peaked at $9.1M in Q1 2019. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

Sio Capital Management reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
Sio Capital Management sold 50,000 Emergent Biosolutions shares in Q2 2021, an estimated $4.65M.
Sio Capital Management first reported a position in Emergent Biosolutions in Q3 2017 and held it in 7 quarters.
Sio Capital Management's Emergent Biosolutions position peaked at $9.1M in Q1 2019.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Sio Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.